Nexia Announces Acquisition of 15% of Inflazyme Pharmaceuticals
Nexia acquired ownership of 19,765,032 Inflazyme shares at a price of Cdn.$400,000 (Cdn.$0.02 per share) pursuant to a private share purchase agreement entered into effective February 6, 2008. Nexia does not currently own any other securities of Inflazyme.
Nexia acquired the Inflazyme shares for investment purposes. Nexia may from time to time acquire additional securities of Inflazyme, dispose of some or all of the existing or additional securities it holds or will hold, or may continue to hold its current position.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.